39
Views
6
CrossRef citations to date
0
Altmetric
Article

Pharmacological inhibition of DNA repair enzymes differentially modulates telomerase activity and apoptosis in two human leukaemia cell lines

, , , , , & show all
Pages 593-605 | Received 03 May 2003, Accepted 20 May 2004, Published online: 03 Jul 2009

References

  • AKIYAMA, M., HIDESIIIIVIA, T., HAYASHI, T., TAI, Y. T., MnsTADEs, C. S., MITSIADES, N., CHAUHAN, D., RICHARDSON, P., MuNsm, N. C. and ANDERSON, K. C., 2002, Cytokines modulate telomerase activity in a human multiple myeloma cell line. Cancer Research, 62, 3876–3882.
  • AKIYAMA, M., HIDESIIIIVIA, T., HAYASHI, T., TAT, Y. T., MITSIADES, C. S., MITSIADES, N., CHAUHAN, D., RICHARDSON, P., MuNsm, N. C. and ANDERSON, K. C., 2003, Nuclear factor kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Research, 63, 18–21.
  • ALDRIDGE, D. R. and RADFORD, I. R., 1998, Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines. Cancer Research, 58, 2817–2824.
  • BELTZ, L. A., 2002, The 'other' telomerase inhibitors: non-G-quadruplex interactive agent, non-antisense, non-reverse transcriptase telomerase inhibitors. Current Medicinal Chemistry — Anti-Cancer Agents, 2, 589–603.
  • BLACKBURN, E. H., 2001, Switching and signaling at the telomere. Cell, 106, 661–673.
  • BOUFFLER, S. D., BLASCO, M. A., Cox, R. and SMITH, P. J., 2001, Telomeric sequences, radiation sensitivity and genomic instability. International Journal of Radiation Biology, 77, 995–1005.
  • BOULTON, S., KYLE, S. and DURKACZ, B. W., 1999, Interactive effects of inhibitors of poly(ADP-ribose) polymerase and DNA-dependent protein kinase on cellular responses to DNA damage. Carcinogenesis, 20, 199–203.
  • CARDOSO, R. S., ESPANHOL, A. R., PASSOS, G. A. and SAKAMOTO-HOJO, E. T., 2002, Differential gene expression in gamma-irradiated BALB/3T3 fibroblasts under the influence of 3-aminobenzamide, an inhibitor of PARP enzyme. Mutation Research, 508, 33–40.
  • CATALDI, A., ZAULI, G., DI PIETRO, R., CASTORINA, S. and RANA, R., 2001, Involvement of the pathway phosphatidylinosito1-3-kinase/AKT-1 in the establishment of the survival response to ionizing radiation. Cell Signalling, 13, 369–375.
  • CHERNIKOVA, S. B., LINDQUIST, K. L. and ELKIND, M. M., 2001, Cell cycle-dependent effects of wortmannin on radiation survival and mutation. Radiation Research, 155, 826–831.
  • CHOW, V. T., QUEK, H. H. and Tom, E. P., 1993, Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line. Cancer Letters, 73, 141–148.
  • CLAVE, E., CAROSELLA, E. D., GtucKmAN, E., DUBRAY, B. and SoctE, G., 1996, Ionizing radiation effects on the KG1 a primitive hematopoietic cell line. International Journal of Radiation Oncology, Biology and Physics, 35, 709–719.
  • Cott's, S. J.5 SWARTZ, M. J., NELSON, W. G. and DEWEESE, T. L., 2003, Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors. Cancer Research, 63, 1550–1554.
  • COSI, C., 2002, New inhibitors of poly(ADP ribose)polymerase and their potential therapeutic targets. Expert Opinion in Therapeutic Patents, 12, 1047–1071.
  • DARZYNKIEWICZ, Z., JUAN, G., Li, X., GORCZYCA, W., MURAKAMI, T. and TRAGANOS, F., 1997, Cytometry in cell necro-biology: analysis of apoptosis and accidental cell death (necrosis). Cytometry, 27, 1–20.
  • DENT, P., YACOUR, A., CONTESSA, J., CARON, R., AMORINO, G., VALERIE, K., HAGAN, M. P., GRANT, S. and SCHMIDT-ULLRICH, R., 2003, Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiation Research, 159, 283–300.
  • EDWARDS, E., GENG, L., TAN, J., ONISHKO, H., DONNELLY, E. and HALLAHAN, D. E., 2002, Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation. Cancer Research, 62, 4671–4677.
  • ENNs, L., MuRRAY, D. and MIRZAYANS, R., 1999, Effects of the protein kinase inhibitors wortmannin and KN62 on cellular radiosensitivity and radiation-activated S phase and G1 /S checkpoints in normal human fibroblasts. British Journal of Cancer, 81, 959–965.
  • FEI, P. and Et-DEIRY, W. S., 2003, P53 and radiation responses. Oncogene, 22, 5774–5783.
  • HARMS-RINGDAHL, M., NICOTERA, P. and RADFORD, I. R., 1996, Radiation induced apoptosis. Mutation Research, 366, 171–179.
  • INANAMI, O., TAKAHASHI, K. and KUWABARA, M., 1999, Attenuation of caspase-3-dependent apoptosis by Trolox post-treatment of X-irradiated MOLT-4 cells. International Journal of Radiation Biology, 75, 155–163.
  • KLEJMAN, A., RUSHEN, L., MORRIONE, A., SLUPIANEK, A. and SKORSKI, T., 2002, Phosphatidylinosito1-3 kinase inhibitors enhance the anti-leukemia effect of STI571. Oncogene, 21, 5868–5876.
  • KYO, S. and INouE, M., 2002, Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy? Oncogene, 21, 688–697.
  • LETEURTRE, F., Li, X., GtuciotAN, E. and CAROSELLA, E. D., 1997, Telomerase activity during the cell cycle and in gamma-irradiated hematopoietic cells. Leukemia, 11, 1681–1689.
  • Li, H., ZHAO, L. L., FuNDER, J. W. and Liu," P., 1997, Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. Journal of Biological Chemistry, 272, 16729–16732.
  • MARPLES, B. and JOINER, M. C., 2000, Modification of survival by DNA repair modifiers: a probable explanation for the phenomenon of increased raclioresistance. International Journal of Radiation Biology, 76, 305–312.
  • NAKAptA, A., TAUGHT, T., SASHIDA, G., Sumt, M., ABE, K., YAMAMOTO, K., OHYASHIKI, J. H. and OHYASHIKI, K., 2003, Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy. Leukemia, 17, 560–567.
  • NAKANO, H., KOHARA, M. and SHINOHARA, K., 2001, Evaluation of the relative contribution of p53-mediated pathway in X-ray induced apoptosis in human leukemic MOLT-4 cells by transfection with a mutant p53 gene at different expression levels. Cell Tissue Research, 306, 101–106.
  • NAKANo, H. and SHINOHARA, K., 1999, Correlation between unirradiated cell TP53 protein levels and racliosensitivity in MOLT-4 cells. Radiation Research, 151, 686–693.
  • NATI, L. M., BORGATTI, P., TAZZARI, P. L., BORTUL, R., CAPELLINI, A., TABELLINI, G., BELLACOSA, A., CAPITANI, S. and MARTELL', A. M., 2003, The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. Molecular Cancer Research, 1, 234–246.
  • NEUHOF, D., RuEss, A., WENZ, F. and WEBER, K. J., 2001, Induction of telomerase activity by irradiation in human lymphoblasts. Radiation Research, 155, 693–697.
  • PEREZ, M. R., DUBNER, D., MICHELIN, S., LETEURTRE, F., GISONE, P. A. and CAROSELLA, E. D., 2002b, Radiation-induced up-regulation of telomerase activity in KG1 a cells is dependent of the dose-rate and radiation quality. International Journal of Radiation Biology, 78, 1175–1183.
  • PEREZ, M. R., DUBNER, D., MICHELIN, S., GISONE, P. and CAROSELLA, E. D., 2002a, Telómeros y reparación de clan() genómico: su implicancia en patologia humana. Medicina (Buenos Aires), 62, 593–603.
  • PINERO, J., LOPEZ BAENA, M., ORTIZ, T. and CORTES, F., 1997, Apoptotic and necrotic cell death are both induced by electroporation in HL60 human promyeloid leukaemia cells. Apoptosis, 2, 330–336.
  • RADFORD, I. R. and MURPHY, T. K., 1994, Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may influence sensitivity to killing by DNA double-strand breakage. International Journal of Radiation Biology, 65, 229–239.
  • RANKIN, P. W., JACOBSON, E. L., BENJAMIN, R. C., Moss, J. and JACOBSON, M. K., 1989, Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. Journal of Biological Chemistry, 264, 4312–4317.
  • RICCIARELLI, R., PALOMBA, L., CANTON', O. and Azzi, A., 1998, 3-Aminobenzamide inhibition of protein kinase C at a cellular level. FEBS Letters, 431, 465–467.
  • ROBERTS, E. C., SHAPIRO, P. S., NAHREINI, T. S., PAGES, G., POUYSSEGUR, J. and AHN, N. G., 2002, Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis. Molecular and Cellular Biology, 22, 7226–7241.
  • SAWANT, S. G., GREGOIRE, V., DHAR, S., UM BRIGHT, C. B., Clam, S., SUKUMAR, S. and PANDrrA, T. K., 1999, Telomerase activity as a measure for monitoring radiocurability of tumor cells. FASEB Journal, 13, 1047–1054.
  • SHALL, S. and DE MURCIA, G., 2000, Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutation Research, 460, 1–15.
  • SHARMA, G. G., GuETA, A., WANG, H., SCHERTHAN, H., DHAR, S., GANDHI, V., "Luaus, G., SHAY, J. W., YOUNG, C. S. and PANDrrA, T. K., 2003, hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene, 22, 131–146.
  • SHENG, W. Y., CHIEN, Y. L. and WANG, T. C., 2003, The dual role of protein kinase C in the regulation of telomerase activity in human lymphocytes. FEBS Letters, 540, 91–95.
  • SLIJEPCEVIC, P. and BRYANT, P. E., 1998, Chromosome healing, telomere capture and mechanisms of radiation-induced chromosome breakage. International Journal of Radiation Biology, 73, 1–13.
  • SOUTHAN, G. J. and SZABO, C., 2003, Poly(ADP-ribose) poly-merase inhibitors. Current Medicinal Chemistry, 10, 321–340.
  • STRUNZ, A. M., PESCHKE, P., WALDECK, W., EHEMANN, V., KISSEL, M. and DEBus, J., 2002, Preferential racliosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control. International Journal of Radiation Biology, 78, 721–732.
  • STUSCHKE, M., SAK, A., WURM, R., SINN, B., WOLF, G., STUB, G. and BUDACH, V., 2002, Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint. International Journal of Radiation Biology, 78, 807–819.
  • SZEKELY, J. G. and LOBREAU, A. U., 1985, High radiosensitivity of the MOLT-4 leukaemic cell line. International Journal of Radiation Biology and Related Studies in Physics and Chemistry Medicine, 48, 277–284.
  • SZKANDEROVA, S., VAVROVA, J., REZACOVA, M., VOKURKOVA, D., PAVLOVA, S., SMARDOVA, J. and STULIK, J., 2003, Gamma irradiation results in phosphorilation of p53 at serine-392 in human T-lymphocyte leukaemia cell line MOLT-4. Folia Biologica (Prague), 49, 183–188.
  • TOMITA, M., SUZUKI, N., MATSUMOTO, Y., ATSUSHI, E., YIN, H. L., HOSOI, Y., HIRANO, K. and SAKAI, K., 2003, Wortmannin-enhanced X-ray-induced apoptosis of human T-cell leukemia MOLT-4 cells possibly through the JNK/ SAPK pathway. Radiation Research, 160, 467–477.
  • VIRAG, L. and SzABo, C., 2002, The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacological Reviews, 54, 375–429.
  • WONG, J. M., KUSDRA, L. and COLLINS, K., 2002, Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nature Cell Biology, 4, 731–736.
  • YOSHIDA, M., HOSOI, Y., MIYACHI, H., Ism', N., MATSUMOTO, Y., ENOMOTO, A., NAKAGAWA, K., YAMADA, S., SUZUKI, N. and ONO, T., 2002, Roles of DNA-dependent protein kinase and ATM in cell-cycle-dependent radiation sensitivity in human cells. International Journal of Radiation Biology, 78, 503–512.
  • YU, C. C., Lo, S. C. and WANG, T. C., 2001, Telomerase is regulated by protein kinase C-zeta in human nasopharyngeal cancer cells. Biochemical Journal, 355, 459–464.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.